{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T12:16:10Z","timestamp":1795176970750,"version":"4.10.3"},"reference-count":66,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ymthe.2025.06.020","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T10:57:08Z","timestamp":1749898628000},"page":"4303-4319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Blood phenylalanine lowering partially reverses white matter changes in a mouse model of phenylketonuria"],"prefix":"10.1016","volume":"33","author":[{"given":"Rachna","family":"Manek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen S.","family":"Cornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Salman","family":"Shazeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Verbitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Berthelette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith L.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Bangari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyou","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3589-8749","authenticated-orcid":false,"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirkka","family":"Kyostio-Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.06.020_bib1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/GIM.0b013e3182141b48","article-title":"Phenylalanine hydroxylase deficiency","volume":"13","author":"Mitchell","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2025.06.020_bib2","first-page":"31","article-title":"Phenylketonuria: an inborn error of phenylalanine metabolism","volume":"29","author":"Williams","year":"2008","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.ymthe.2025.06.020_bib3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/humu.22980","article-title":"Genetics of Phenylketonuria: Then and Now","volume":"37","author":"Blau","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2025.06.020_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.abb.2012.12.017","article-title":"A new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeutics","volume":"530","author":"Jaffe","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymthe.2025.06.020_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1750-1172-8-133","article-title":"Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis","volume":"8","author":"de Groot","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2025.06.020_bib6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ymgme.2009.10.005","article-title":"White matter pathology in phenylketonuria","volume":"99","author":"Anderson","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2025.06.020_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.spen.2016.11.007","article-title":"Impaired Neurotransmission in Early-treated Phenylketonuria Patients","volume":"23","author":"Gonzalez","year":"2016","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.020_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13023-018-0912-5","article-title":"White matter microstructural damage in early treated phenylketonuric patients","volume":"13","author":"Gonzalez","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2025.06.020_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s13346-012-0067-1","article-title":"Clinical therapeutics for phenylketonuria","volume":"2","author":"Kochhar","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ymthe.2025.06.020_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2010.05.017","article-title":"Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence","volume":"101","author":"Enns","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2025.06.020_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ymgme.2019.12.007","article-title":"5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics","volume":"129","author":"Levy","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2025.06.020_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fpsyt.2019.00561","article-title":"Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments","volume":"10","author":"Ashe","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.ymthe.2025.06.020_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13023-015-0227-8","article-title":"Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience","volume":"10","author":"Scala","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2025.06.020_bib14","doi-asserted-by":"crossref","first-page":"e1881","DOI":"10.1542\/peds.2012-3291","article-title":"Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study","volume":"131","author":"Keil","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymthe.2025.06.020_bib15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.omtm.2020.03.009","article-title":"Sustained Correction of a Murine Model of Phenylketonuria following a Single Intravenous Administration of AAVHSC15-PAH","volume":"17","author":"Ahmed","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.020_bib16","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1038\/s41467-024-47460-9","article-title":"Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria","volume":"15","author":"Baek","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.06.020_bib17","first-page":"1583","article-title":"Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria","volume":"22","author":"Phillips","year":"2001","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"10.1016\/j.ymthe.2025.06.020_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00692698","article-title":"Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria","volume":"58","author":"Bauman","year":"1982","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2025.06.020_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymgme.2020.12.001","article-title":"Inter- and intra-tract analysis of white matter abnormalities in individuals with early-treated phenylketonuria (PKU)","volume":"132","author":"Clocksin","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2025.06.020_bib20","first-page":"177","article-title":"Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment","volume":"6","author":"Battistini","year":"1991","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.020_bib21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00005072-199607000-00005","article-title":"Evidence for central nervous system glial cell plasticity in phenylketonuria","volume":"55","author":"Dyer","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.020_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0014-4886(92)90200-A","article-title":"Disturbed myelinogenesis and recovery in hyperphenylalaninemia in rats: an immunohistochemical study","volume":"115","author":"Reynolds","year":"1992","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.020_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-4547(20000901)61:5<549::AID-JNR10>3.0.CO;2-0","article-title":"Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse?","volume":"61","author":"Shefer","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymthe.2025.06.020_bib24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF00973296","article-title":"Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia","volume":"13","author":"Castillo","year":"1988","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymthe.2025.06.020_bib25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11011-021-00676-w","article-title":"Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling","volume":"36","author":"Bortoluzzi","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymthe.2025.06.020_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbadis.2005.02.005","article-title":"Oxidative stress in patients with phenylketonuria","volume":"1740","author":"Sirtori","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2025.06.020_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jnnp.2008.162859","article-title":"Adults with late diagnosed PKU and severe challenging behaviour","volume":"80","author":"van Spronsen","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymthe.2025.06.020_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/genetics\/134.4.1205","article-title":"Mouse models of human phenylketonuria","volume":"134","author":"Shedlovsky","year":"1993","journal-title":"Genetics"},{"key":"10.1016\/j.ymthe.2025.06.020_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/geno.1996.4508","article-title":"Characterization of mutations at the mouse phenylalanine hydroxylase locus","volume":"39","author":"McDonald","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2025.06.020_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10545-010-9052-3","article-title":"Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites","volume":"33","author":"Schoemans","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2025.06.020_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02267-2","article-title":"Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria","volume":"11","author":"Manek","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.06.020_bib32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","article-title":"Cholesterol metabolism and homeostasis in the brain","volume":"6","author":"Zhang","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.ymthe.2025.06.020_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.gt.3302678","article-title":"Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2\/8 vector-mediated gene therapy in murine phenylketonuria","volume":"13","author":"Harding","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.020_bib34","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nprot.2006.170","article-title":"Assessing nest building in mice","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2025.06.020_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00230371","article-title":"Effect of phenylalanine derivatives on the main regulatory enzymes of hepatic cholesterogenesis","volume":"105","author":"Castillo","year":"1991","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ymthe.2025.06.020_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jnr.24598","article-title":"White matter disturbances in phenylketonuria: Possible underlying mechanisms","volume":"99","author":"Ferreira","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymthe.2025.06.020_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-3476(95)70303-9","article-title":"Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change","volume":"127","author":"Cleary","year":"1995","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymthe.2025.06.020_bib38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1471-4159.2003.01887.x","article-title":"Relationship between myelin production and dopamine synthesis in the PKU mouse brain","volume":"86","author":"Joseph","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymthe.2025.06.020_bib39","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1007\/PL00014371","article-title":"The neuropathology of phenylketonuria: human and animal studies","volume":"159","author":"Huttenlocher","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymthe.2025.06.020_bib40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1523\/JNEUROSCI.0849-14.2015","article-title":"Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration","volume":"35","author":"Moyon","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.020_bib41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrd.2017.115","article-title":"Remyelination therapies: a new direction and challenge in multiple sclerosis","volume":"16","author":"Plemel","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.06.020_bib42","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1038\/s41598-020-60699-8","article-title":"The Role of Transthyretin in Oligodendrocyte Development","volume":"10","author":"Alshehri","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.06.020_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6070071","article-title":"Evidence of Oxidative Stress and Secondary Mitochondrial Dysfunction in Metabolic and Non-Metabolic Disorders","volume":"6","author":"Stepien","year":"2017","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymthe.2025.06.020_bib44","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00018-021-03802-0","article-title":"Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders","volume":"78","author":"Spaas","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2025.06.020_bib45","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1002\/jnr.22139","article-title":"Oxidative stress disrupts oligodendrocyte maturation","volume":"87","author":"French","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymthe.2025.06.020_bib46","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.expneurol.2016.03.009","article-title":"The multifaceted role of astrocytes in regulating myelination","volume":"283","author":"Kiray","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.020_bib47","first-page":"71","article-title":"Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair","volume":"4","author":"Domingues","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2025.06.020_bib48","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.4103\/1673-5374.306064","article-title":"Astrocytes: a double-edged sword in neurodegenerative diseases","volume":"16","author":"Ding","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ymthe.2025.06.020_bib49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/1098-1136(200009)31:3<267::AID-GLIA80>3.0.CO;2-N","article-title":"GFAP null astrocytes are a favorable substrate for neuronal survival and neurite growth","volume":"31","author":"Menet","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2025.06.020_bib50","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1038\/s41467-023-39046-8","article-title":"Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration","volume":"14","author":"Molina-Gonzalez","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.06.020_bib51","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tem.2016.03.018","article-title":"LXR Regulation of Brain Cholesterol: From Development to Disease","volume":"27","author":"Courtney","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2025.06.020_bib52","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","article-title":"Brain cholesterol: long secret life behind a barrier","volume":"24","author":"Bjorkhem","year":"2004","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymthe.2025.06.020_bib53","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.1620506114","article-title":"Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism","volume":"114","author":"Ferris","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.06.020_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac288","article-title":"Ependymal cells and neurodegenerative disease: outcomes of compromised ependymal barrier function","volume":"4","author":"Nelles","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.ymthe.2025.06.020_bib55","doi-asserted-by":"crossref","first-page":"18707","DOI":"10.1074\/jbc.R113.479808","article-title":"Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR)","volume":"288","author":"Sharpe","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.06.020_bib56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cca.2012.10.011","article-title":"Oxysterol changes along with cholesterol and vitamin D changes in adult phenylketonuric patients diagnosed by newborn mass-screening","volume":"416","author":"Nagasaka","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymthe.2025.06.020_bib57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.redox.2016.09.001","article-title":"Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation","volume":"10","author":"Testa","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.ymthe.2025.06.020_bib58","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth","volume":"8","author":"Saher","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.020_bib59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/hgtb.2016.124","article-title":"Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection","volume":"28","author":"Nambiar","year":"2017","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2025.06.020_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"Plos Biol."},{"key":"10.1016\/j.ymthe.2025.06.020_bib61","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","article-title":"Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway","volume":"102","author":"Davidoff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.06.020_bib62","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1089\/hum.2009.031","article-title":"Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders","volume":"20","author":"Paneda","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.020_bib63","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1038\/s41598-021-86663-8","article-title":"CRISPR\/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuria","volume":"11","author":"Singh","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.06.020_bib64","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41593-019-0491-3","article-title":"Single-cell transcriptomic profiling of the aging mouse brain","volume":"22","author":"Ximerakis","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.020_bib65","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1126\/science.aaf6463","article-title":"Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system","volume":"352","author":"Marques","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.06.020_bib66","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","article-title":"Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics","volume":"19","author":"Street","year":"2018","journal-title":"BMC Genomics"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162500471X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162500471X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:22:40Z","timestamp":1782505360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162500471X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":66,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S152500162500471X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.06.020","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood phenylalanine lowering partially reverses white matter changes in a mouse model of phenylketonuria","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sanofi. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}